| Product Code: ETC9690363 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Non-Cardioselective Beta Blockers Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Non-Cardioselective Beta Blockers Market - Industry Life Cycle |
3.4 Thailand Non-Cardioselective Beta Blockers Market - Porter's Five Forces |
3.5 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume Share, By Target, 2021 & 2031F |
3.7 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Thailand Non-Cardioselective Beta Blockers Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hypertension and cardiovascular diseases in Thailand |
4.2.2 Growing awareness about the benefits of non-cardioselective beta blockers in managing heart conditions |
4.2.3 Rising healthcare expenditure and improving healthcare infrastructure in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and marketing of pharmaceutical products |
4.3.2 Availability of alternative treatment options for cardiovascular diseases |
4.3.3 Concerns regarding potential side effects and adverse reactions associated with non-cardioselective beta blockers |
5 Thailand Non-Cardioselective Beta Blockers Market Trends |
6 Thailand Non-Cardioselective Beta Blockers Market, By Types |
6.1 Thailand Non-Cardioselective Beta Blockers Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Angina, 2021- 2031F |
6.1.4 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Hypertension, 2021- 2031F |
6.1.5 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Heart Failure, 2021- 2031F |
6.1.6 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Arrhythmias, 2021- 2031F |
6.1.7 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Thailand Non-Cardioselective Beta Blockers Market, By Target |
6.2.1 Overview and Analysis |
6.2.2 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Beta-1 Receptors, 2021- 2031F |
6.2.3 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Beta-2 Receptors, 2021- 2031F |
6.2.4 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Thailand Non-Cardioselective Beta Blockers Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Propranolol, 2021- 2031F |
6.3.3 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Nadolol, 2021- 2031F |
6.3.4 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Labetalol, 2021- 2031F |
6.3.5 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Carvedilol, 2021- 2031F |
6.3.6 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Sotalol, 2021- 2031F |
6.3.7 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Timolol, 2021- 2031F |
6.3.8 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Others, 2021- 2031F |
6.3.9 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Thailand Non-Cardioselective Beta Blockers Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Thailand Non-Cardioselective Beta Blockers Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Thailand Non-Cardioselective Beta Blockers Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.4 Thailand Non-Cardioselective Beta Blockers Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Thailand Non-Cardioselective Beta Blockers Market Import-Export Trade Statistics |
7.1 Thailand Non-Cardioselective Beta Blockers Market Export to Major Countries |
7.2 Thailand Non-Cardioselective Beta Blockers Market Imports from Major Countries |
8 Thailand Non-Cardioselective Beta Blockers Market Key Performance Indicators |
8.1 Number of prescriptions for non-cardioselective beta blockers issued by healthcare providers |
8.2 Patient adherence rate to non-cardioselective beta blocker treatment regimens |
8.3 Number of clinical trials and research studies conducted on non-cardioselective beta blockers in Thailand |
9 Thailand Non-Cardioselective Beta Blockers Market - Opportunity Assessment |
9.1 Thailand Non-Cardioselective Beta Blockers Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Thailand Non-Cardioselective Beta Blockers Market Opportunity Assessment, By Target, 2021 & 2031F |
9.3 Thailand Non-Cardioselective Beta Blockers Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 Thailand Non-Cardioselective Beta Blockers Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Thailand Non-Cardioselective Beta Blockers Market Opportunity Assessment, By End User, 2021 & 2031F |
9.6 Thailand Non-Cardioselective Beta Blockers Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Thailand Non-Cardioselective Beta Blockers Market - Competitive Landscape |
10.1 Thailand Non-Cardioselective Beta Blockers Market Revenue Share, By Companies, 2024 |
10.2 Thailand Non-Cardioselective Beta Blockers Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here